Scarica l'app Stockscreener
335.94
0.99%
-3.36
Dopo l'orario di chiusura:
335.58
-0.36
-0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen Named One of Newsweek’s Most Trustworthy Companies in America 2026 - Amgen
Amgen's Growth Engine Is Just Getting Started (NASDAQ:AMGN) - Seeking Alpha
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits? - TradingView
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Assessing Amgen (AMGN) Valuation After Japan Safety Concerns Over Rare Disease Drug - simplywall.st
Fisher Asset Management LLC Purchases 118,273 Shares of Amgen Inc. $AMGN - MarketBeat
My Personal Plan to Turn Market Chaos Into 300%+ Growth - Investing.com
Allstate Corp Has $13.13 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock (US0311621009): CFO retirement and earnings strength keep focus on guidance - AD HOC NEWS
Mita Ganatra Joins Amgen India as Executive Director, Finance - hrtoday.in
Amgen (AMGN) Announces Retirement of CFO Peter Griffith - Insider Monkey
Wealthquest Corp Acquires Shares of 3,374 Amgen Inc. $AMGN - MarketBeat
Legal & General Group Plc Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by New Age Alpha Advisors LLC - MarketBeat
Simplify Asset Management Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Strong ROE and Promising Outlook in the Healthcare Sector - DirectorsTalk Interviews
Amgen Inc. $AMGN Shares Sold by Swedbank AB - MarketBeat
Amgen Inc. $AMGN is Smead Capital Management Inc.'s 5th Largest Position - MarketBeat
Amgen stock (US0311621009): Shares edge lower after early-February trade update - AD HOC NEWS
Amgen stock (US0311621009): earnings beat and leadership change put biotech giant in focus - AD HOC NEWS
Does Amgen’s CFO Transition and Board Structure Shape a New Governance Story for AMGN? - simplywall.st
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Legato Capital Management LLC Acquires Shares of 8,328 Amgen Inc. $AMGN - MarketBeat
Axxcess Wealth Management LLC Raises Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Americana Partners LLC - MarketBeat
Amgen Inc. stock (US0311621009): weight-loss data and obesity ambitions move into focus - AD HOC NEWS
Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Amgen Inc. (NASDAQ: AMGN) Stock Trades Near $330 as Japan Drug Safety Crisis Raises Concerns - foreignpolicyjournal.com
Amgen Inc. stock (US0311621009): obesity data, Horizon deal and pipeline put focus back on the biote - AD HOC NEWS
Keudell Morrison Wealth Management Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media
Global Retirement Partners LLC Purchases 5,691 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Stock Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate - Yahoo Finance
Amgen Inc. Stock 12‑Month Price Target Cut to $352.32, Implies 4% Upside - TradingView
Amgen stock (US0311621009): Q1 revenue tops estimates, CFO change keeps debt in focus - AD HOC NEWS
Amgen (AMGN) director Amy E. Miles awarded 665 RSUs, now holds 5,640 shares - Stock Titan
Amgen (AMGN) director Ellen Kullman receives 665-share RSU equity grant - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665 RSUs in stock award - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665-share equity award, now holds 18,284 - Stock Titan
Amgen Shareholders Reaffirm Board, Pay and Auditors - The Globe and Mail
Amgen (AMGN) director Omar Ishrak receives 665-share stock grant in Form 4 - Stock Titan
Amgen (AMGN) director Charles Holley receives 665-share RSU grant and reports 12.8K direct holdings - Stock Titan
Amgen (AMGN) director Garland receives 665 RSUs that vest immediately - Stock Titan
Amgen (AMGN) director receives 665 RSUs in immediate stock grant - Stock Titan
Amgen (NASDAQ: AMGN) director Brian Druker receives 665-share RSU grant - Stock Titan
Amgen (AMGN) director Michael V. Drake receives 665-share RSU award - Stock Titan
Amgen (AMGN) director receives 665-share RSU stock grant award - Stock Titan
Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses - CFO Dive
Amgen Wants To Preserve Right To Seek Double Tax Relief - Law360
Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline - simplywall.st
Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ
Amgen's Q1 earnings top estimates, 16 drugs deliver double-digit gains - MSN
The Escalator: Amgen, CG Life, Cosette Pharmaceuticals and more - Medical Marketing and Media
IFP Advisors Inc Has $3.92 Million Stake in Amgen Inc. $AMGN - MarketBeat
Liquidity Mapping Around (AMGN) Price Events - Stock Traders Daily
Amgen Inc. (AMGN): Navellier’s Long-Term Pick on Pipeline Strength and Sales Growth - Insider Monkey
ABN Amro Investment Solutions Acquires 13,431 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen's CFO resigns – a successor has been named - medwatch.com
Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Amgen Inc. 8-K Filing May 2026: Executive Compensation Approval and Shareholder Voting Results - Minichart
Declaration of Voting Results by Amgen Inc - marketscreener.com
Amgen (NASDAQ: AMGN) investors reject independent chair proposal - Stock Titan
As Griffith retires, Dittrich returns to Amgen, takes CFO role - biocentury.com
The Story of Maridebart Cafraglutide (MariTide) - Amgen
Amgen’s Approach to AI-Enabled Clinical Development - Amgen
Amgen : Approach to AI-Enabled Clinical Development - marketscreener.com
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer - TipRanks
Amgen Inc. stock (US0311621009): Weight-loss drug data and guidance update keep investors on alert - AD HOC NEWS
1.71%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):